Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Nov 12, 2024
- Accession no.
- 0001415889-24-026613
- Filed
- Nov 12, 2024
- Trade date
- Nov 11, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 21 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.11M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | Common Stock | MOption exerciseAcquired | +11,250 | $102.11 | +$1,148,737.5 | 11,250 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −741 | $401.02 | −$297,155.82 | 10,509 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −456 | $402.47 | −$183,526.32 | 10,053 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −1,361 | $403.31 | −$548,904.91 | 8,692 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −1,142 | $404.31 | −$461,722.02 | 7,550 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −742 | $405.37 | −$300,784.54 | 6,808 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −428 | $406.56 | −$174,007.68 | 6,380 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −1,381 | $407.77 | −$563,130.37 | 4,999 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −1,670 | $409.06 | −$683,130.2 | 3,329 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −3,030 | $410.54 | −$1,243,936.2 | 299 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −216 | $410.86 | −$88,745.76 | 83 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −83 | $412.25 | −$34,216.75 | 0 | Indirect | |
| Nov 11, 2024 | Common Stock | MOption exerciseAcquired | +3,750 | $111.00 | +$416,250 | 3,750 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −426 | $405.20 | −$172,615.2 | 3,324 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −89 | $406.63 | −$36,190.07 | 3,235 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −1,294 | $407.82 | −$527,719.08 | 1,941 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −1,451 | $408.77 | −$593,125.27 | 490 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −284 | $409.26 | −$116,229.84 | 206 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −106 | $410.29 | −$43,490.74 | 100 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −84 | $411.63 | −$34,576.92 | 16 | Indirect | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −16 | $412.64 | −$6,602.24 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | Common Stock | MOption exerciseDisposed | −11,250 | $0.00 | $0 | 27,000 | Indirect | |
| Nov 11, 2024 | Common Stock | MOption exerciseDisposed | −3,750 | $0.00 | $0 | 42,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.